Aarti Industries lifts margin, but tax benefit cushions profit and shares fall
Revenue rose 13.17% year on year and margin improved, but interest costs jumped 75.61% and the stock fell more than its usual post-results move.
Filed 04 May 2026, 18:10 IST · after market close · Aarti Industries Ltd (AARTIIND)
Key takeaways
- Q4FY26 operating margin rose 1.75 percentage points year on year to 15.54% as expenses grew slower than revenue.
- Net profit grew 43.32% year on year, helped by a tax benefit that took the tax rate to -23.62%.
- The stock fell 4.89% on the first trading day after results, versus a 1.84% median absolute move after the last eight results.
Price around the results
Margin improved despite sequential revenue decline
Consolidated revenue fell 4.88% sequentially, but expenses fell faster at 6.73%, lifting operating margin by 1.68 percentage points to 15.54%. Year on year, revenue grew 13.17% while expenses rose 10.87%, producing a 1.75-percentage-point margin expansion. Management said Q4 volume growth covered all key products except MPDA.
Interest costs offset part of the operating gain
Interest expense rose 63.90% sequentially and 75.61% year on year, even as depreciation fell 1.98% sequentially. Management attributed higher finance costs to export-led working-capital growth and said they included a Rs 39 cr foreign-currency loan revaluation impact. Other income was only -0.82% of pre-tax profit, so it did not materially support earnings.
Tax benefit drove the sequential profit increase
Pre-tax profit fell 6.29% sequentially, but net profit rose 3.31% because the tax rate declined by 11.49 percentage points to -23.62%. Year on year, the tax-rate change was 15.37 percentage points, helping net profit grow 43.32% despite the sharp rise in interest expense. The tax benefit makes the reported profit increase less representative of operating improvement than the margin gain.
Margin reached a quarter high but remains below peers
Operating margin has risen from 12.58% in Q3FY25 to 15.54% in Q4FY26, with the latest quarter reversing the 0.01-percentage-point sequential dip in Q3FY26. Aarti Industries' margin was 3.23 percentage points below the 18.77% median for the 51 Commodities peers that had reported. Management said 70% of ideas from its cost-savings drive had been implemented and targets EBITDA of Rs 1,800-2,200 cr, Debt/EBITDA below 2.5x and ROCE above 15%.
Shares fell more than the usual post-results move
The stock declined 4.89% on the first trading day after the results and was down 8.69% five sessions later. That reaction was notably weaker than the company's typical post-results move: the median absolute move across the last eight results was 1.84%, with five declines and three gains. Management said PDA utilisation remains under pressure from US tariffs and Chinese competition, while NT and Ethylation utilisation is expected to improve in CY26.
Q4FY26 at a glance
Consolidated figures as filed with NSE — cross-checked against an independent source.
| Line item | Q4FY26 | Q3FY26 | QoQ | YoY |
|---|---|---|---|---|
| Revenue | ₹2,206 cr | ₹2,319 cr | -4.88% | +13.17% |
| Other income | ₹-1 cr | ₹-13 cr | +93.23% | +69.05% |
| Expenses | ₹1,863 cr | ₹1,997 cr | -6.73% | +10.87% |
| Operating profit | ₹343 cr | ₹321 cr | +6.66% | +27.58% |
| Operating margin (%) | 15.54% | 13.86% | — | — |
| Interest | ₹112 cr | ₹69 cr | +63.90% | +75.61% |
| Depreciation | ₹119 cr | ₹121 cr | -1.98% | +4.59% |
| Profit before tax | ₹111 cr | ₹119 cr | -6.29% | +25.51% |
| Tax | ₹-26 cr | ₹-14 cr | -82.41% | -259.32% |
| Net profit | ₹137 cr | ₹133 cr | +3.31% | +43.32% |
| EPS (₹) | ₹3.79 | ₹3.67 | +3.27% | +43.56% |
Operating margin of 15.54% compares with a Commodities sector median of 18.77% across 51 peers that have reported Q4FY26.
How the stock reacted
| Window | Stock | vs NIFTY |
|---|---|---|
| Results day | -4.89% | -4.53% |
| Next session | -2.97% | — |
| 5 sessions | -8.69% | -5.63% |
| 15 sessions | -4.31% | — |
| 30 sessions | -6.61% | — |
Volume on the results session was 4.05× its 20-day average.
What management said
From the company’s own investor presentation. Each point is checked against the source document before it appears here.
This quarter
- Q4 volume growth occurred across all key products except MPDA.
Guidance & outlook
- The company targets EBITDA of ₹1,800-2,200 crore, Debt/EBITDA below 2.5x and ROCE above 15%.
- Operating leverage and cost optimisation initiatives are expected to drive EBITDA growth beyond volume growth.
- NT and Ethylation utilization is expected to improve in CY26 with DEA downstream integration and increasing MEA demand.
Expansion
- MMA capacity increased to 290 kTPA and further expansion to 360 kTPA is underway.
- DCB capacity debottlenecking to 140 kT is underway, supported by PDCB and downstream demand.
- The PEDA capacity is under commissioning trials as part of DEA downstream integration.
- The Superform downstream JV has invested about 70% of its targeted amount and is expected to commission in H1FY27.
- The company plans FY26 capex of about ₹1,125 crore.
New initiatives
- A cost savings drive generated ideas on product yield, energy efficiency, digital analytics and engineering solutions, with 70% implemented.
- The company is using digital and advanced analytics as part of its cost excellence initiatives.
Problems & risks
- PDA utilization is affected by US tariffs and competition from China and is expected to remain under pressure.
- Zone IV projects were delayed by three to four months due to labour constraints and war-related issues.
- Higher exports increased working capital, debt and finance costs, including a ₹39 crore foreign-currency loan revaluation impact.
What to watch
- Whether consolidated operating margin holds above 15.54% after the Q4FY26 improvement.
- Whether interest expense moves below Rs 112.32 cr as export-linked working capital and finance costs are monitored.
- Progress on the 290 kTPA MMA capacity, the planned expansion to 360 kTPA and PEDA commissioning trials.